News & Views

Media Coverage

CTI Exchange: Contraception Technology Innovation is Everyone’s Business, Writes Julia Bunting and Laneta Dorflinger

In a blog post for FHI 360’s Contraceptive Technology Innovation Exchange, Julia Bunting, President of the Population Council, and Laneta Dorflinger, Distinguished Scientist and Director for Contraceptive Technology, outline what needs to be done to increase access to the broadest choice of quality, affordable, and acceptable contraceptives.

Read more

Media Coverage

POZ: FDA Approval of PrEP for Adolescents is a Great Start, Writes Council Expert

Council researcher Nanlesta Pilgrim writes about the U.S. Food and Drug Administration (FDA)'s recent decision to expand the approval of Truvada as pre-exposure prophylaxis (PrEP) against HIV for use in at-risk adolescents and the continued need to improve services for adolescents, in the U.S. and around the world. 

Read more